Response obstructive sleep apnea Protripyline pharmacologic agent obstructive sleep apnea OSA anticholinergic side effects intolerable many patients serotonin central respiratory stimulant serotonin-uptake inhibitor fluoxetine tolerated fluoxetine treatment OSA effect fluoxetine protriptyline patients OSA drugs proportion REM sleep time number apneas hypopneas NREM sleep response equivalent protriptyline group whole significant improvement number arterial oxygen desaturation events level arterial oxygen desaturation number arousals agent wide variability response medication patients good responses improvement oxygenation fluoxetine protriptyline patients trial protriptyline fluoxetine beneficial patients OSA Fluoxetine protriptyline 